Smruti Phadnis
Publication Details
-
Human bone marrow-derived mesenchymal cells differentiate and mature into endocrine pancreatic lineage in vivo.
Cytotherapy. 2011; (3): 279-93
The scarcity of human islets for transplantation remains a major limitation of cell replacement therapy for diabetes. Bone marrow-derived progenitor cells are of interest because they can be isolated, expanded and offered for such therapy under autologous/allogeneic settings.
